170 related articles for article (PubMed ID: 17259861)
21. Methylation status of the reelin promoter region in the brain of schizophrenic patients.
Tochigi M; Iwamoto K; Bundo M; Komori A; Sasaki T; Kato N; Kato T
Biol Psychiatry; 2008 Mar; 63(5):530-3. PubMed ID: 17870056
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic regulation of RELN and GAD1 in the frontal cortex (FC) of autism spectrum disorder (ASD) subjects.
Zhubi A; Chen Y; Guidotti A; Grayson DR
Int J Dev Neurosci; 2017 Nov; 62():63-72. PubMed ID: 28229923
[TBL] [Abstract][Full Text] [Related]
23. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability.
Tremolizzo L; Carboni G; Ruzicka WB; Mitchell CP; Sugaya I; Tueting P; Sharma R; Grayson DR; Costa E; Guidotti A
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):17095-100. PubMed ID: 12481028
[TBL] [Abstract][Full Text] [Related]
24. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study.
Guidotti A; Auta J; Davis JM; Di-Giorgi-Gerevini V; Dwivedi Y; Grayson DR; Impagnatiello F; Pandey G; Pesold C; Sharma R; Uzunov D; Costa E
Arch Gen Psychiatry; 2000 Nov; 57(11):1061-9. PubMed ID: 11074872
[TBL] [Abstract][Full Text] [Related]
25. Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters.
Dong E; Guidotti A; Grayson DR; Costa E
Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4676-81. PubMed ID: 17360583
[TBL] [Abstract][Full Text] [Related]
26. Reelin promoter hypermethylation in schizophrenia.
Grayson DR; Jia X; Chen Y; Sharma RP; Mitchell CP; Guidotti A; Costa E
Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9341-6. PubMed ID: 15961543
[TBL] [Abstract][Full Text] [Related]
27. The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes.
Kundakovic M; Chen Y; Guidotti A; Grayson DR
Mol Pharmacol; 2009 Feb; 75(2):342-54. PubMed ID: 19029285
[TBL] [Abstract][Full Text] [Related]
28. GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon.
Guidotti A; Auta J; Davis JM; Dong E; Grayson DR; Veldic M; Zhang X; Costa E
Psychopharmacology (Berl); 2005 Jul; 180(2):191-205. PubMed ID: 15864560
[TBL] [Abstract][Full Text] [Related]
29. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum.
Fatemi SH; Stary JM; Earle JA; Araghi-Niknam M; Eagan E
Schizophr Res; 2005 Jan; 72(2-3):109-22. PubMed ID: 15560956
[TBL] [Abstract][Full Text] [Related]
30. A missed exit: Reelin sets in motion Dab1 polyubiquitination to put the break on neuronal migration.
Kerjan G; Gleeson JG
Genes Dev; 2007 Nov; 21(22):2850-4. PubMed ID: 18006681
[No Abstract] [Full Text] [Related]
31. Chronic psychotropic drug treatment causes differential expression of Reelin signaling system in frontal cortex of rats.
Fatemi SH; Reutiman TJ; Folsom TD
Schizophr Res; 2009 Jun; 111(1-3):138-52. PubMed ID: 19359144
[TBL] [Abstract][Full Text] [Related]
32. Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation.
Dong E; Nelson M; Grayson DR; Costa E; Guidotti A
Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13614-9. PubMed ID: 18757738
[TBL] [Abstract][Full Text] [Related]
33. A variant in the reelin gene increases the risk of schizophrenia and schizoaffective disorder but not bipolar disorder.
Pisanté A; Bronstein M; Yakir B; Darvasi A
Psychiatr Genet; 2009 Aug; 19(4):212. PubMed ID: 19436241
[No Abstract] [Full Text] [Related]
34. Gene expression profiling in Brodmann's area 46 from subjects with schizophrenia.
Dean B; Keriakous D; Scarr E; Thomas EA
Aust N Z J Psychiatry; 2007 Apr; 41(4):308-20. PubMed ID: 17464717
[TBL] [Abstract][Full Text] [Related]
35. [Epigenetic model in the pharmacologic modulation of vulnerability to schizophrenia].
Tremolizzo L
Encephale; 2007 Nov; 33(Pt 3):867-9. PubMed ID: 18402359
[No Abstract] [Full Text] [Related]
36. Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression.
Behan AT; Byrne C; Dunn MJ; Cagney G; Cotter DR
Mol Psychiatry; 2009 Jun; 14(6):601-13. PubMed ID: 18268500
[TBL] [Abstract][Full Text] [Related]
37. Nicotine decreases DNA methyltransferase 1 expression and glutamic acid decarboxylase 67 promoter methylation in GABAergic interneurons.
Satta R; Maloku E; Zhubi A; Pibiri F; Hajos M; Costa E; Guidotti A
Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16356-61. PubMed ID: 18852456
[TBL] [Abstract][Full Text] [Related]
38. Altered expression of schizophrenia-related genes in mice lacking mGlu5 receptors.
Luoni A; Gass P; Brambilla P; Ruggeri M; Riva MA; Inta D
Eur Arch Psychiatry Clin Neurosci; 2018 Feb; 268(1):77-87. PubMed ID: 27581816
[TBL] [Abstract][Full Text] [Related]
39. Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders.
Akbarian S; Huang HS
Brain Res Rev; 2006 Sep; 52(2):293-304. PubMed ID: 16759710
[TBL] [Abstract][Full Text] [Related]
40. GABAergic cortical neuron chromatin as a putative target to treat schizophrenia vulnerability.
Costa E; Grayson DR; Mitchell CP; Tremolizzo L; Veldic M; Guidotti A
Crit Rev Neurobiol; 2003; 15(2):121-42. PubMed ID: 14977367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
